Mi-2β promotes immune evasion in melanoma by activating EZH2 methylation

Recent development of new immune checkpoint inhibitors has been particularly successfully in cancer treatment, but still the majority patients fail to benefit. Converting resistant tumors to immunotherapy sensitive will provide a significant improvement in patient outcome. Here we identify Mi-2β as...

全面介绍

书目详细资料
Main Authors: Li, C, Wang, Z, Yao, L, Lin, X, Jian, Y, Li, Y, Zhang, J, Shao, J, Tran, PD, Hagman, JR, Cao, M, Cong, Y, Li, H-Y, Goding, CR, Xu, Z-X, Liao, X, Miao, X, Cui, R
格式: Journal article
语言:English
出版: Springer Nature 2024